485

Submitted by admin on
Action
JAK
Alt Name
ASP015K
ASP-015K
Approval Jurisdiction
2021 Japan
Approved for clinical use
Rhematoid arthritis
Brutto
C18H22N4O2
CAS
944118-01-8
Commercial Vendor
Astellas Janssen
Compound Image
Peficitinib.png
Compound name
Peficitinib
InChI
InChI=1S/C18H22N4O2/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22)/t9?,10-,11+,14?,18?
InChI Key
DREIJXJRTLTGJC-JQCLMNFQSA-N
MW
326.40
PubChem CID
57928403
SMILES
C1C2CC3CC(C2)(CC1C3NC4=C5C=CNC5=NC=C4C(=O)N)O
Approved Drug List
1